Treatment Approaches for Patients With Oligodendrogliomas and Grade 2 Gliomas
Panelists discuss how they tailor treatment strategies for oligodendrogliomas and Grade 2 gliomas based on key clinical and molecular markers, with particular attention to insights from the CODEL trial and RTOG 9802 study.
- How do you approach treatment decisions for patients with oligodendrogliomas and Grade 2 gliomas? What clinical and molecular factors most significantly influence your approach?
- CODEL TRIAL
- RTOG 9802